Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Given Consensus Recommendation of “Moderate Buy” by Brokerages
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report) has earned a consensus rating of “Moderate Buy” from the eight ratings firms that are presently covering the firm, Marketbeat Ratings reports. Four analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12-month price objective […]
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report) has earned a consensus rating of “Moderate Buy” from the eight ratings firms that are presently covering the firm, Marketbeat Ratings reports. Four analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12-month price objective […]
